Gelesis announces merger with Capstar SpecialGelesis, a biotherapeutics company advancing biomimetic superabsorbent hydrogels to treat excess weight and metabolic disorders, and...
Plenity induced weight loss results in NALFD fibrosis score improvementA post-hoc analysis showed that treatment for weight management with Plenity decreased a marker for liver fibrosis (the NAFLD fibrosis...
Gelesis gains European approval for PLENITY weight loss treatmentGelesis, a biotechnology company developing a novel hydrogel platform technology to treat obesity and other chronic diseases related to...